Andexanet alfa for reversal of rivaroxaban in a child with intracranial hemorrhage

被引：3
|
作者：
Takasaki, Kaoru [1 ]
Hehir, David [2 ,3 ,4 ,5 ]
Raffini, Leslie [6 ,7 ]
Samelson-Jones, Benjamin J. [6 ,7 ,8 ]
Shih, Evelyn [1 ,9 ,10 ,11 ]
Dain, Aleksandra Sarah [1 ]
机构：
[1] Childrens Hosp Philadelphia, Div Hematol & Oncol, 3615 Civic Ctr Blvd,Room 314E, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA USA
[3] Childrens Hosp Philadelphia, Div Cardiac Crit Care, Philadelphia, PA USA
[4] Univ Penn, Perelman Sch Med, Dept Anesthesia, Philadelphia, PA USA
[5] Univ Penn, Perelman Sch Med, Dept Crit Care, Philadelphia, PA USA
[6] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA USA
[7] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[8] Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA USA
[9] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA USA
[10] Univ Penn, Dept Neurol, Philadelphia, PA USA
[11] Univ Penn, Dept Pediat, Philadelphia, PA USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷 / 06期
基金：
美国国家卫生研究院;
关键词：
VENOUS THROMBOSIS;
D O I：
10.1002/pbc.29484
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages
    Pham, Haithuy
    Medford, Whitney Gibson
    Horst, Spencer
    Levesque, Melissa
    Ragoonanan, David
    Price, Christine
    Colbassani, Harold
    Piper, Keaton
    Chastain, Keith
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 55 : 38 - 44
  • [22] Reversal of Anticoagulation Effects of Rivaroxaban and Associated Bleeding in a Rabbit Acute Hemorrhage Model by Andexanet Alfa vs. Coagulation Replacement Factors
    Lu, Genmin
    Pine, Polly
    DeGuzman, Francis
    Canivel, Deogracias
    Malinowski, John
    Pratikhya, Pratikhya
    Lin, Joyce
    Leeds, Janet M.
    Curnutte, John T.
    Conley, Pamela B.
    NEUROLOGY, 2017, 88
  • [23] Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis
    Olivia S. Costa
    Stuart J. Connolly
    Mukul Sharma
    Jan Beyer-Westendorf
    Mary J. Christoph
    Belinda Lovelace
    Craig I. Coleman
    Critical Care, 26
  • [24] Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis
    Costa, Olivia S.
    Connolly, Stuart J.
    Sharma, Mukul
    Beyer-Westendorf, Jan
    Christoph, Mary J.
    Lovelace, Belinda
    Coleman, Craig I.
    CRITICAL CARE, 2022, 26 (01)
  • [25] Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage ANNEXA-4 Substudy
    Demchuk, Andrew M.
    Yue, Patrick
    Zotova, Elena
    Nakamya, Juliet
    Xu, Lizhen
    Milling, Truman J., Jr.
    Ohara, Tomoyuki
    Goldstein, Joshua N.
    Middeldorp, Saskia
    Verhamme, Peter
    Lopez-Sendon, Jose Luis
    Conley, Pamela B.
    Curnutte, John T.
    Eikelboom, John W.
    Crowther, Mark
    Connolly, Stuart J.
    STROKE, 2021, 52 (06) : 2096 - 2105
  • [26] A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers
    Lu, Genmin
    Conley, Pamela B.
    Leeds, Janet M.
    Karbarz, Mark J.
    Levy, Gallia G.
    Mathur, Vandana S.
    Castillo, Janice
    Crowther, Mark
    Curnutte, John T.
    BLOOD ADVANCES, 2020, 4 (04) : 728 - 739
  • [27] The use of andexanet alfa and 4-factor prothrombin complex concentrate in intracranial hemorrhage
    Oh, Elly S.
    Schulze, Paul
    Diaz, Frank
    Shah, Kunal
    Rios, Jose
    Silverman, Michael E.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2023, 64 : 74 - 77
  • [28] Efficacy and Safety With Andexanet Alfa in Traumatic Intracranial Hemorrhage: An ANNEXA-4 Substudy
    Milling, T. J.
    Yue, P.
    Zotova, E.
    Nakamya, J.
    Curnutte, J. T.
    Connolly, S. J.
    Demchuk, A. M.
    ANNALS OF EMERGENCY MEDICINE, 2019, 74 (04) : S78 - S79
  • [29] Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
    Troyer, Camille
    Nguyen, Wesley
    Xie, Annie
    Wimer, Dexter
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (01) : 149 - 155
  • [30] The Use of Andexanet Alfa Vs. Four-Factor Prothrombin Complex Concentrates in the Reversal of Life-Threatening Intracranial Hemorrhage
    Gatell, Vivian Irizarry
    Bacchus, Michael
    De Leo, Edward
    Zhang, Yang
    Lagasse, Carrie
    Khanna, Anna Y.
    Harris, Neil
    Zumberg, Marc S.
    BLOOD, 2022, 140 : 5696 - 5697
12345